- Home
- MRNA vs NVT Comparison
MRNA vs NVT Comparison
Compare MRNA & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- NVT
- Stock Information
- Founded
- MRNA 2010
- NVT 1903
- Country
- MRNA United States
- NVT United Kingdom
- Employees
- MRNA N/A
- NVT N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- NVT Industrial Machinery/Components
- Sector
- MRNA Health Care
- NVT Industrials
- Exchange
- MRNA Nasdaq
- NVT Nasdaq
- Market Cap
- MRNA 13.4B
- NVT 11.5B
- IPO Year
- MRNA 2018
- NVT N/A
- Fundamental
- Price
- MRNA $34.15
- NVT $78.54
- Analyst Decision
- MRNA Hold
- NVT Strong Buy
- Analyst Count
- MRNA 20
- NVT 11
- Target Price
- MRNA $46.76
- NVT $77.45
- AVG Volume (30 Days)
- MRNA 9.4M
- NVT 1.9M
- Earning Date
- MRNA 08-01-2025
- NVT 08-01-2025
- Dividend Yield
- MRNA N/A
- NVT 1.02%
- EPS Growth
- MRNA N/A
- NVT 1.65
- EPS
- MRNA N/A
- NVT 3.49
- Revenue
- MRNA $3,177,000,000.00
- NVT $3,083,300,000.00
- Revenue This Year
- MRNA N/A
- NVT $19.82
- Revenue Next Year
- MRNA $9.70
- NVT $9.30
- P/E Ratio
- MRNA N/A
- NVT $54.58
- Revenue Growth
- MRNA N/A
- NVT 15.90
- 52 Week Low
- MRNA $23.15
- NVT $41.71
- 52 Week High
- MRNA $125.68
- NVT $81.20
- Technical
- Relative Strength Index (RSI)
- MRNA 64.57
- NVT 69.95
- Support Level
- MRNA $30.88
- NVT $73.05
- Resistance Level
- MRNA $35.59
- NVT $77.70
- Average True Range (ATR)
- MRNA 1.48
- NVT 2.21
- MACD
- MRNA 0.11
- NVT -0.01
- Stochastic Oscillator
- MRNA 74.05
- NVT 96.88
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About NVT nVent Electric plc
nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.